Prof. Azmat Ali Khan

Azmat Ali Khan obtained a PhD from the Interdisciplinary Biotechnology Unit, Aligarh Muslim University, India. During his PhD, he synthesized novel fatty acid conjugates and evaluated their anticancer potential both in cancer cell lines and nanoparticle-based drug formulations on the cancer mouse model. Research collaborations with some basic, as well as advanced, studies of my work have been published in journals of repute, such as Lipids, Nanomedicine, Anticancer Research, etc. Other than this, I have also worked on the development of vaccines for combating an important fungal disease; Cryptococcosis. This work received worldwide attention. My published work in this area (Khan et al., 2012, J Drug Target.) was included in the top 50 articles in the area of fungal vaccine research in Recent Medical Findings for the years between 2008 and 2013. I have developed broad expertise in the life science research area; however, my research is primarily targeted to determine new and friendly conjugates that can be used as potential chemotherapeutic agents employing nano-delivery against cancer. Moreover, the research is focused on understanding the mechanism of action of various synthetic conjugates toward cancer cells to apprehend their functions.